HIPRA BIOTECH SERVICES, SA.

Exhibitor

HIPRA Biotech Services is a CDMO supporting pharma and biotech companies through the full lifecycle of biologics and vaccines. With over 50 years of expertise in biologics development, manufacturing, and commercialization — and our own COVID-19 vaccine — we offer end-to-end development and GMP manufacturing across viral, mammalian, and microbial platforms to produce both clinical and commercial drug substance and drug product for our clients.
Our scientific and technical excellence ensures agility and seamless integration across all stages of the product lifecycle, while our unwavering commitment to quality is demonstrated by GMP certifications and an excellent inspection record.

With more than 400 R&D scientists and 1,000 engineers, operators, and analysts, supported by state-of-the-art facilities and top-of-the-line equipment within the European Union, we offer an integrated value chain that delivers quality, speed, and flexibility in every project.

At HIPRA Biotech Services, we are driven by the enthusiasm to make your project our own, working side by side with our partners to enhance and accelerate their success in bringing innovative biologics and vaccines to patients worldwide.